bioAffinity Technologies Q2 EPS $(0.19) Up From $(0.20) YoY, Sales $2.40M Up From $19.74K YoY
Portfolio Pulse from Benzinga Newsdesk
bioAffinity Technologies (NASDAQ:BIAF) reported Q2 EPS of $(0.19), an improvement from $(0.20) YoY, and sales of $2.40M, a significant increase from $19.74K YoY.
August 14, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
bioAffinity Technologies reported a Q2 EPS of $(0.19), an improvement from $(0.20) YoY, and a significant increase in sales to $2.40M from $19.74K YoY.
The improvement in EPS and the substantial increase in sales indicate positive financial performance, which is likely to have a favorable impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100